查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1941420

药物研发外包市场规模、份额和趋势分析报告：按工作流程、药物、服务、治疗领域、最终用途、地区和细分市场预测，2026-2033年

Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Workflow, By Drug, By Service, By Therapeutics Area, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

药物研发外包市场概况

2025年全球药物研发外包市场规模估计为80.8亿美元，预计2033年将达到171.1亿美元。

预计从 2026 年到 2033 年，该市场将以 10.0% 的复合年增长率成长。推动该市场成长的关键因素包括药物研发活动的增加、治疗方法复杂性的增加、研发成本的上升以及对更快上市时间的日益增长的需求。

此外，疾病负担加重、对生物製药和基因疗法等新型治疗方法的需求不断增长，以及人工智慧和高通量筛检等先进技术的应用，也促进了市场成长。

其他推动市场成长的因素包括：为获取专业知识、先进技术和可扩展的研究基础设施，药物研发活动外包的趋势日益明显。此外，人工智慧药物研发技术的日益普及以及对生物製剂和标靶治疗的需求不断增长，也促进了市场成长。同时，外包能够分担风险、提高营运柔软性并优化成本，使其成为专利到期期间极具吸引力的策略，有助于加剧全球製药业的竞争，从而推动市场成长。

製药业正经历重大变革，包括专利到期、生物製药的兴起以及大型製药企业内部药物研发部门前所未有的缩减，这些变革预计将推动市场成长。此外，研发投入的增加和新药开发投资的扩大也是生技和製药产业的关键趋势。例如，生物製药产业约75%至80%的研发成本可以外包，这将进一步为合约研究组织（CRO）创造新的成长机会，并促进市场成长。

由于开发中国家的生产设施建立合作关係。降低成本、提高创新能力、获取知识和技术以及提升速度和灵活性是製药公司增加外包规模的关键驱动因素。此外，公共和公共部门对创新治疗方法的研发和发现的兴趣也显着增加。多家大型製药企业正在投资开发新型解决方案，以巩固其市场地位。创业投资也大幅成长，尤其是在生命科学领域。

此外，技术进步是推动全球药物研发外包产业成长和结构演变的根本动力。随着治疗标靶日益复杂，业界致力于提高早期研究阶段的效率并降低失败率，这促使先进药物研发技术广泛应用。随着製药和生物技术公司重新评估自身能力，拥有专有技术平台的外包合作伙伴应运而生，受託研究机构（CRO）的地位也从单纯的服务提供者转变为创新催化剂。

此外，全球高品质和严格的监管合规性、国际卓越的科研水平（尤其是在高需求的研究领域）、快速且无与伦比的交付速度以及复杂但具有竞争力的定价机制，都推动了市场竞争。同时，企业间日益增多的合作和专业知识预计将进一步推动药物研发外包产业的发展。各机构正在寻求并扩大与学术机构、创业投资以及其他公私人公司的资金筹措联盟，以利用其专利技术和分子。公私人公司间日益密切的合作正在加速药物研发进程，并提升全球对外包服务的需求。此外，美国、印度、中国、韩国、新加坡和其他东南亚国家等主要国家涌现的众多新兴Start-Ups也促进了市场成长。例如，2025年3月，Syngene International宣布收购其在美国的首个生物製剂製造地。该设施包括多条单株抗体（mAb）生产线，原为位于巴尔的摩的Emergent Manufacturing Operations, Inc.。这将进一步巩固 Syngene 在生物製剂领域的全球地位，使其能够为人类和动物保健市场的客户提供服务。

目录

第一章调查方法和范围

第二章执行摘要

第三章：药物研发外包市场变数、趋势与范围

  • 市场谱系展望
    • 母市场展望
    • 相关及辅助市场展望
  • 市场动态
  • 定价模式分析
  • 科技趋势
  • 市场分析工具
    • 波特五力分析
    • PESTEL 分析与 SWOT 分析

第四章：药物研发外包市场：依工作流程分類的估算与趋势分析

  • 药物研发外包市场：依工作流程分析波动状况
  • 2021-2033年药物研发外包市场依工作流程分類的估算与预测
  • 目标识别与筛检
  • 目标检验和功能资讯学
  • 先导化合物筛选及候选化合物优化
  • 临床前开发
  • 其他的

第五章：药物研发外包市场：依药物类型分類的估算与趋势分析

  • 药物研发外包市场：按药物分類的波动分析
  • 2021-2033年按药物类型分類的药物研发外包市场估算与预测
  • 低分子
  • 聚合物

第六章：药物研发外包市场：依服务类型分類的估算与趋势分析

  • 药物研发外包市场：按服务类型分類的波动分析
  • 药物研发外包市场按服务类型分類的估算与预测，2021-2033年
  • 化学服务
  • 生物服务

第七章：药物研发外包市场：依治疗领域分類的估算与趋势分析

  • 药物研发外包市场：依治疗领域分類的波动分析
  • 2021-2033年按治疗领域分類的药物研发外包市场估算与预测
  • 呼吸系统
  • 疼痛和麻醉
  • 肿瘤学
  • 眼科
  • 血液学
  • 循环系统
  • 内分泌学
  • 消化器官系统
  • 免疫调节
  • 抗感染疾病
  • 中枢神经系统
  • 皮肤科
  • 泌尿生殖系统
  • 其他的

第八章：药物研发外包市场：依最终用途分類的估算与趋势分析

  • 药物研发外包市场：依最终用途分類的差异分析
  • 2021-2033年按最终用途分類的药物研发外包市场估算与预测
  • 製药和生物技术公司
  • 学术机构

第九章：药物研发外包市场：区域估算与趋势分析

  • 区域市场概览
  • 区域市场占有率分析（2025 年和 2033 年）
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 泰国
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特
    • 阿曼
    • 卡达

第十章 竞争格局

  • 市场参与企业分类
  • 公司市占率/估值分析（2025 年）
  • 公司简介
    • Albany Molecular Research Inc.（Curia Global, Inc.）
    • EVOTEC
    • Laboratory Corporation of America Holdings.
    • GenScript
    • Thermo Fisher Scientific, Inc.
    • Charles River Laboratories International, Inc.
    • WuXi AppTec
    • Merck &Co., Inc.
    • Dalton Pharma Services
    • Oncodesign
    • Jubilant Biosys
    • QIAGEN
    • Eurofins SE
    • Syngene International Limited
    • Dr. Reddy Laboratories Ltd.
    • Pharmaron Beijing Co., Ltd.
    • TCG Lifesciences Pvt Ltd.
    • Domainex Ltd.

第十一章 主要建议

Product Code: GVR-2-68038-392-8

Drug Discovery Outsourcing Market Summary

The global drug discovery outsourcing market size was estimated at USD 8.08 billion in 2025 and is projected to reach USD 17.11 billion by 2033, growing at a CAGR of 10.0% from 2026 to 2033. The market growth is driven by increasing drug development activities, the growing complexity of therapeutics, rising R&D costs, and a growing need to accelerate time-to-market.

Besides, there is an increasing burden of diseases, a rising demand for novel modalities such as biologics and gene therapies, and the adoption of advanced technologies, including AI and high-throughput screening.

There are several other factors contributing to the market growth include the increasing outsourcing of discovery activities to access specialized expertise, advanced technologies, and scalable research infrastructure. In addition, growing adoption of AI-based drug discovery, increased demand for biologics, and targeted therapies are contributing to the market growth. Moreover, outsourcing enables risk sharing, operational flexibility, and cost optimization, making it an attractive strategy amid patent expirations and propelling competition in the global pharmaceutical landscape, which is expected to drive market growth.

The pharmaceutical industry has experienced significant transformations, including the expiration of patents, a trend toward biologics, and unprecedented downsizing of internal discovery of big pharmaceuticals, which is expected to drive the market growth. Besides, an increase in R&D funding and investments in novel drug development is a crucial trend in the biotechnology and pharmaceutical industries. For instance, around 75.0% to 80.0% of research and development spending in the biopharmaceutical industry can be outsourced, further propelling new growth opportunities for CROs, which is expected to boost market growth.

Pharmaceutical companies are partnering with manufacturing facilities in developing countries, backed by skilled workforces, low costs, and quality data. Cost-cutting, innovation, gaining access to knowledge and technology, and increasing speed and agility are significant factors encouraging pharma companies to expand the level of outsourcing. Moreover, there has been a considerable increase in interest from both private and public sectors in the development and discovery of innovative therapies. Several major pharmaceutical companies are investing in the development of novel solutions to establish a strong market position. There has also been a considerable increase in venture capital investments, especially in the life sciences sector.

Moreover, technological advancements are a fundamental driver shaping the growth and structural evolution of the global drug discovery outsourcing industry. The rising complexity of therapeutic targets, along with the industry's focus on increasing productivity and reducing attrition rates in early-stage research stages has led to greater adoption of advanced discovery technologies. As pharmaceutical and biotech companies reevaluate their internal capabilities, outsourcing partners with unique technological platforms, strengthening the position of contract research organizations (CROs) as innovation facilitators rather than just service providers.

Furthermore, the market competition is driven by high quality and strict compliance to regulations worldwide, international scientific excellence, especially in the most demanded research areas, speed and unbeatable timelines to delivery, and complex, competitive prices. In addition, companies are increasingly collaborating and leveraging expertise, which is expected to drive the drug discovery outsourcing industry. Organizations are undertaking & extending strategic partnerships with many academic institutions, venture capitalists for funding, and other public or private companies to exploit patented technology, molecules, and more. Rising partnerships among public and private entities accelerate drug discovery processes, increasing the global demand for outsourcing. In addition, emergence of various new startups across the hotspot countries, such as the U.S., India, China, South Korea, Singapore, & other Southeast Asian countries are contributing to the market's growth. For instance, in March 2025, Syngene International Limited announced the acquisition of its first biologics site in the USA, which includes several manufacturing lines for monoclonal antibodies (mAbs). The site was acquired from Emergent Manufacturing Operations in Baltimore, enhancing Syngene's expanding global presence in the biologics sector and enabling the company to serve clients in both the human and animal health markets.

Global Drug Discovery Outsourcing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global drug discovery outsourcing market report based on workflow, drug, service, therapeutics area, end use, and region.

  • Workflow Outlook (Revenue, USD Million, 2021 - 2033)
  • Target Identification & Screening
  • Target Validation & Functional Informatics
  • Lead Identification & Candidate Optimization
  • Preclinical Development
  • Others
  • Drug Outlook (Revenue, USD Million, 2021 - 2033)
  • Small Molecules
  • Large Molecules
  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Chemistry Services
  • Biology Services
  • Therapeutics Area Outlook (Revenue, USD Million, 2021 - 2033)
  • Respiratory system
  • Pain and Anesthesia
  • Oncology
  • Ophthalmology
  • Hematology
  • Cardiovascular
  • Endocrine
  • Gastrointestinal
  • Immunomodulation
  • Anti-infective
  • Central Nervous System
  • Dermatology
  • Genitourinary System
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology companies
  • Academic Institutes
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Thailand
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Oman
    • Qatar

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Workflow
    • 1.2.2. Drug
    • 1.2.3. Service
    • 1.2.4. Therapeutics Area
    • 1.2.5. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Drug Discovery Outsourcing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing R&D in biopharmaceutical industry
      • 3.2.1.2. Increasing demand for outsourcing services in drug development
      • 3.2.1.3. Technological advancements in drug discovery
      • 3.2.1.4. Rising incidence rate of metabolic, genetic, and other chronic diseases
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Presence of open-source software packages for drug discovery
      • 3.2.2.2. High operational costs and risk of drug failure
  • 3.3. Pricing Model Analysis
  • 3.4. Technology Landscape
  • 3.5. Market Analysis Tools
    • 3.5.1. Porter's Five Force Analysis
    • 3.5.2. PESTEL by SWOT Analysis

Chapter 4. Drug Discovery Outsourcing Market: Workflow Estimates & Trend Analysis

  • 4.1. Drug Discovery Outsourcing Market, By Workflow: Segment Dashboard
  • 4.2. Drug Discovery Outsourcing Market, By Workflow: Movement Analysis
  • 4.3. Drug Discovery Outsourcing Market Estimates & Forecasts, By Workflow, 2021 - 2033 (USD Million)
  • 4.4. Target Identification & Screening
    • 4.4.1. Target Identification & Screening Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Target Validation & Functional Informatics
    • 4.5.1. Target Validation & Functional Informatics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Lead Identification & Candidate Optimization
    • 4.6.1. Lead Identification & Candidate Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Preclinical Development
    • 4.7.1. Preclinical Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Drug Discovery Outsourcing Market: Drug Estimates & Trend Analysis

  • 5.1. Drug Discovery Outsourcing Market, By Drug: Segment Dashboard
  • 5.2. Drug Discovery Outsourcing Market, By Drug: Movement Analysis
  • 5.3. Drug Discovery Outsourcing Market Estimates & Forecasts, By Drug, 2021 - 2033 (USD Million)
  • 5.4. Small Molecules
    • 5.4.1. Small Molecules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Large Molecules
    • 5.5.1. Large Molecules Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Drug Discovery Outsourcing Market: Service Estimates & Trend Analysis

  • 6.1. Drug Discovery Outsourcing Market, By Service: Segment Dashboard
  • 6.2. Drug Discovery Outsourcing Market, By Service: Movement Analysis
  • 6.3. Drug Discovery Outsourcing Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
  • 6.4. Chemistry Services
    • 6.4.1. Chemistry Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Biology Services
    • 6.5.1. Biology Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Drug Discovery Outsourcing Market: Therapeutics Area Estimates & Trend Analysis

  • 7.1. Drug Discovery Outsourcing Market, By Therapeutics Area: Segment Dashboard
  • 7.2. Drug Discovery Outsourcing Market, By Therapeutics Area: Movement Analysis
  • 7.3. Drug Discovery Outsourcing Market Estimates & Forecasts, By Therapeutics Area, 2021 - 2033 (USD Million)
  • 7.4. Respiratory System
    • 7.4.1. Respiratory System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Pain and Anesthesia
    • 7.5.1. Pain and Anesthesia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Oncology
    • 7.6.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Ophthalmology
    • 7.7.1. Ophthalmology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Hematology
    • 7.8.1. Hematology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.9. Cardiovascular
    • 7.9.1. Cardiovascular Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.10. Endocrine
    • 7.10.1. Endocrine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.11. Gastrointestinal
    • 7.11.1. Gastrointestinal Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.12. Immunomodulation
    • 7.12.1. Immunomodulation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.13. Anti-infective
    • 7.13.1. Anti-infective Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.14. Central Nervous System
    • 7.14.1. Central Nervous System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.15. Dermatology
    • 7.15.1. Dermatology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.16. Genitourinary System
    • 7.16.1. Genitourinary System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.17. Others
    • 7.17.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Drug Discovery Outsourcing Market: End Use Estimates & Trend Analysis

  • 8.1. Drug Discovery Outsourcing Market, By End Use: Segment Dashboard
  • 8.2. Drug Discovery Outsourcing Market, By End Use: Movement Analysis
  • 8.3. Drug Discovery Outsourcing Market Estimates & Forecasts, By End Use, 2021 - 2033 (USD Million)
  • 8.4. Pharmaceutical & Biotechnology companies
    • 8.4.1. Pharmaceutical & Biotechnology companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Academic Institutes
    • 8.5.1. Academic Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Drug Discovery Outsourcing Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Dashboard
  • 9.2. Regional Market Share Analysis, 2025 & 2033
  • 9.3. North America
    • 9.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.2. U.S
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Competitive Scenario
      • 9.3.2.3. Regulatory Framework
      • 9.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Competitive Scenario
      • 9.3.3.3. Regulatory Framework
      • 9.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Competitive Scenario
      • 9.3.4.3. Regulatory Framework
      • 9.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4. Europe
    • 9.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.2. UK
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Competitive Scenario
      • 9.4.2.3. Regulatory Framework
      • 9.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.3. Germany
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Competitive Scenario
      • 9.4.3.3. Regulatory Framework
      • 9.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.4. France
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Competitive Scenario
      • 9.4.4.3. Regulatory Framework
      • 9.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Competitive Scenario
      • 9.4.5.3. Regulatory Framework
      • 9.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Competitive Scenario
      • 9.4.6.3. Regulatory Framework
      • 9.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.7. Denmark
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Competitive Scenario
      • 9.4.7.3. Regulatory Framework
      • 9.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.8. Sweden
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Competitive Scenario
      • 9.4.8.3. Regulatory Framework
      • 9.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.9. Norway
      • 9.4.9.1. Key Country Dynamics
      • 9.4.9.2. Competitive Scenario
      • 9.4.9.3. Regulatory Framework
      • 9.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.2. Japan
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competitive Scenario
      • 9.5.2.3. Regulatory Framework
      • 9.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.3. China
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competitive Scenario
      • 9.5.3.3. Regulatory Framework
      • 9.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.4. India
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Competitive Scenario
      • 9.5.4.3. Regulatory Framework
      • 9.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.5. Thailand
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Competitive Scenario
      • 9.5.5.3. Regulatory Framework
      • 9.5.5.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.6. South Korea
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Competitive Scenario
      • 9.5.6.3. Regulatory Framework
      • 9.5.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.7. Australia
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Competitive Scenario
      • 9.5.7.3. Regulatory Framework
      • 9.5.7.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competitive Scenario
      • 9.6.2.3. Regulatory Framework
      • 9.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competitive Scenario
      • 9.6.3.3. Regulatory Framework
      • 9.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7. MEA
    • 9.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.2. South Africa
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Competitive Scenario
      • 9.7.2.3. Regulatory Framework
      • 9.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.3. Saudi Arabia
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Competitive Scenario
      • 9.7.3.3. Regulatory Framework
      • 9.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.4. UAE
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Competitive Scenario
      • 9.7.4.3. Regulatory Framework
      • 9.7.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key Country Dynamics
      • 9.7.5.2. Competitive Scenario
      • 9.7.5.3. Regulatory Framework
      • 9.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.6. Oman
      • 9.7.6.1. Key Country Dynamics
      • 9.7.6.2. Competitive Scenario
      • 9.7.6.3. Regulatory Framework
      • 9.7.6.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.7. Qatar
      • 9.7.7.1. Key Country Dynamics
      • 9.7.7.2. Competitive Scenario
      • 9.7.7.3. Regulatory Framework
      • 9.7.7.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Market Participant Categorization
  • 10.2. Company Market Share/Assessment Analysis, 2025
  • 10.3. Company Profiles
    • 10.3.1. Albany Molecular Research Inc. (Curia Global, Inc.)
      • 10.3.1.1. Company Overview
      • 10.3.1.2. Financial Performance
      • 10.3.1.3. Service Benchmarking
      • 10.3.1.4. Strategic Initiatives
    • 10.3.2. EVOTEC
      • 10.3.2.1. Company Overview
      • 10.3.2.2. Financial Performance
      • 10.3.2.3. Service Benchmarking
      • 10.3.2.4. Strategic Initiatives
    • 10.3.3. Laboratory Corporation of America Holdings.
      • 10.3.3.1. Company Overview
      • 10.3.3.2. Financial Performance
      • 10.3.3.3. Service Benchmarking
      • 10.3.3.4. Strategic Initiatives
    • 10.3.4. GenScript
      • 10.3.4.1. Company Overview
      • 10.3.4.2. Financial Performance
      • 10.3.4.3. Service Benchmarking
      • 10.3.4.4. Strategic Initiatives
    • 10.3.5. Thermo Fisher Scientific, Inc.
      • 10.3.5.1. Company Overview
      • 10.3.5.2. Financial Performance
      • 10.3.5.3. Service Benchmarking
      • 10.3.5.4. Strategic Initiatives
    • 10.3.6. Charles River Laboratories International, Inc.
      • 10.3.6.1. Company Overview
      • 10.3.6.2. Financial Performance
      • 10.3.6.3. Service Benchmarking
      • 10.3.6.4. Strategic Initiatives
    • 10.3.7. WuXi AppTec
      • 10.3.7.1. Company Overview
      • 10.3.7.2. Financial Performance
      • 10.3.7.3. Service Benchmarking
      • 10.3.7.4. Strategic Initiatives
    • 10.3.8. Merck & Co., Inc.
      • 10.3.8.1. Company Overview
      • 10.3.8.2. Financial Performance
      • 10.3.8.3. Service Benchmarking
      • 10.3.8.4. Strategic Initiatives
    • 10.3.9. Dalton Pharma Services
      • 10.3.9.1. Company Overview
      • 10.3.9.2. Financial Performance
      • 10.3.9.3. Service Benchmarking
      • 10.3.9.4. Strategic Initiatives
    • 10.3.10. Oncodesign
      • 10.3.10.1. Company Overview
      • 10.3.10.2. Financial Performance
      • 10.3.10.3. Service Benchmarking
      • 10.3.10.4. Strategic Initiatives
    • 10.3.11. Jubilant Biosys
      • 10.3.11.1. Company Overview
      • 10.3.11.2. Financial Performance
      • 10.3.11.3. Service Benchmarking
      • 10.3.11.4. Strategic Initiatives
    • 10.3.12. QIAGEN
      • 10.3.12.1. Company Overview
      • 10.3.12.2. Financial Performance
      • 10.3.12.3. Service Benchmarking
      • 10.3.12.4. Strategic Initiatives
    • 10.3.13. Eurofins SE
      • 10.3.13.1. Company Overview
      • 10.3.13.2. Financial Performance
      • 10.3.13.3. Service Benchmarking
      • 10.3.13.4. Strategic Initiatives
    • 10.3.14. Syngene International Limited
      • 10.3.14.1. Company Overview
      • 10.3.14.2. Financial Performance
      • 10.3.14.3. Service Benchmarking
      • 10.3.14.4. Strategic Initiatives
    • 10.3.15. Dr. Reddy Laboratories Ltd.
      • 10.3.15.1. Company Overview
      • 10.3.15.2. Financial Performance
      • 10.3.15.3. Service Benchmarking
      • 10.3.15.4. Strategic Initiatives
    • 10.3.16. Pharmaron Beijing Co., Ltd.
      • 10.3.16.1. Company Overview
      • 10.3.16.2. Financial Performance
      • 10.3.16.3. Service Benchmarking
      • 10.3.16.4. Strategic Initiatives
    • 10.3.17. TCG Lifesciences Pvt Ltd.
      • 10.3.17.1. Company Overview
      • 10.3.17.2. Financial Performance
      • 10.3.17.3. Service Benchmarking
      • 10.3.17.4. Strategic Initiatives
    • 10.3.18. Domainex Ltd.
      • 10.3.18.1. Company Overview
      • 10.3.18.2. Financial Performance
      • 10.3.18.3. Service Benchmarking
      • 10.3.18.4. Strategic Initiatives

Chapter 11. Key Recommendations

List of Tables

  • Table 1 List of Tables
  • Table 2 List of Secondary Sources
  • Table 3 List of Abbreviations
  • Table 4 Global Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 5 Global Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 6 Global Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 7 Global Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 8 Global Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 9 Global Drug Discovery Outsourcing Market Estimates and Forecasts, by Region, 2021 - 2033 (USD Million)
  • Table 10 North America Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 11 North America Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 12 North America Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 13 North America Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 14 North America Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 15 North America Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 16 U . Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 17 U.S Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 18 U.S Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 19 U.S Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 20 U.S Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 21 Canada Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 22 Canada Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 23 Canada Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 24 Canada Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 25 Canada Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 26 Mexico Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 27 Mexico Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 28 Mexico Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 29 Mexico Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 30 Mexico Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 31 Europe Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 32 Europe Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 33 Europe Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 34 Europe Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 35 Europe Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 36 Europe Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 37 UK Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 38 UK Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 39 UK Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 40 UK Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 41 UK Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 42 Germany Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 43 Germany Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 44 Germany Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 45 Germany Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 46 Germany Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 47 France Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 48 France Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 49 France Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 50 France Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 51 France Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 52 Italy Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 53 Italy Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 54 Italy Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 55 Italy Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 56 Italy Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 57 Spain Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 58 Spain Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 59 Spain Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 60 Spain Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 61 Spain Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 62 Denmark Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 63 Denmark Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 64 Denmark Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 65 Denmark Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 66 Denmark Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 67 Sweden Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 68 Sweden Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 69 Sweden Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 70 Sweden Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 71 Sweden Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 72 Norway Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 73 Norway Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 74 Norway Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 75 Norway Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 76 Norway Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 77 Asia Pacific Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 78 Asia Pacific Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 79 Asia Pacific Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 80 Asia Pacific Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 81 Asia Pacific Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 82 Asia Pacific Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 83 Japan Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 84 Japan Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 85 Japan Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 86 Japan Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 87 Japan Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 88 China Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 89 China Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 90 China Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 91 China Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 92 China Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 93 India Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 94 India Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 95 India Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 96 India Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 97 India Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 98 Thailand Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 99 Thailand Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 100 Thailand Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 101 Thailand Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 102 Thailand Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 103 South Korea Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 104 South Korea Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 105 South Korea Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 106 South Korea Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 107 South Korea Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 108 Australia Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 109 Australia Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 110 Australia Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 111 Australia Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 112 Australia Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 113 Latin America Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 114 Latin America Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 115 Latin America Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 116 Latin America Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 117 Latin America Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 118 Latin America Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 119 Brazil Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 120 Brazil Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 121 Brazil Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 122 Brazil Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 123 Brazil Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 124 Argentina Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 125 Argentina Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 126 Argentina Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 127 Argentina Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 128 Argentina Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 129 Middle East & Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 130 Middle East & Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 131 Middle East & Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 132 Middle East & Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 133 Middle East & Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 134 Middle East & Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 135 South Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 136 South Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 137 South Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 138 South Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 139 South Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 140 Saudi Arabia Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 141 Saudi Arabia Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 142 Saudi Arabia Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 143 Saudi Arabia Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 144 Saudi Arabia Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 145 UAE Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 146 UAE Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 147 UAE Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 148 UAE Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 149 UAE Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 150 Kuwait Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 151 Kuwait Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 152 Kuwait Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 153 Kuwait Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 154 Kuwait Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 155 Oman Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 156 Oman Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 157 Oman Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 158 Oman Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 159 Oman Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 160 Qatar Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 161 Qatar Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
  • Table 162 Qatar Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 163 Qatar Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 164 Qatar Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2025 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2025 (USD Billion)
  • Fig. 16 Drug Discovery Outsourcing Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Drug Discovery Outsourcing Market: Workflow outlook and key takeaways
  • Fig. 20 Drug Discovery Outsourcing Market: Workflow movement analysis
  • Fig. 21 Target Identification & Screening Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Target Validation & Functional Informatics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Lead Identification & Candidate Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Preclinical Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Other Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Drug Discovery Outsourcing Market: Drug outlook and key takeaways
  • Fig. 27 Drug Discovery Outsourcing Market: Drug movement analysis
  • Fig. 28 Small Molecules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Large Molecules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Drug Discovery Outsourcing Market: Service outlook and key takeaways
  • Fig. 31 Drug Discovery Outsourcing Market: Service movement analysis
  • Fig. 32 Chemistry Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Biology Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Drug Discovery Outsourcing Market: Therapeutics Area outlook and key takeaways
  • Fig. 35 Drug Discovery Outsourcing Market: Therapeutics Area movement analysis
  • Fig. 36 Respiratory system Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Pain and Anesthesia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Ophthalmology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Hematology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Cardiovascular Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Endocrine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Gastrointestinal Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Immunomodulation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Anti-infective Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Central Nervous System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Dermatology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Genitourinary System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Drug Discovery Outsourcing Market: End Use outlook and key takeaways
  • Fig. 50 Drug Discovery Outsourcing Market: End Use movement analysis
  • Fig. 51 Pharmaceutical & Biotechnology companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Academic Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Regional Marketplace: Key Takeaways
  • Fig. 54 North America Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 U.S. Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Canada Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Mexico Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Europe Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 UK Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Germany Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 France Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Italy Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Spain Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Denmark Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Sweden Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Norway Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Asia Pacific Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Japan Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 China Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 India Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Thailand Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 South Korea Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Australia Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 Latin America Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Brazil Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Argentina Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 MEA Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 South Africa Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Saudi Arabia Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 UAE Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 103 Key country dynamics
  • Fig. 104 Kuwait Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 105 Key country dynamics
  • Fig. 106 Oman Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 Qatar Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 109 Key company categorization
  • Fig. 110 Service heat map analysis
  • Fig. 111 Strategic framework